Stevenage Bioscience Catalyst joins o2h Discovery Platinum Partner Programme to strengthen support for early-stage biotech

Stevenage Bioscience Catalyst (SBC) has joined the o2h Discovery Platinum Partner Programme, creating a new opportunity for eligible biotech companies within its community to access specialist drug discovery expertise and resources.

The new collaboration further strengthens the support available to early-stage companies at SBC, connecting them with additional expertise in areas including medicinal chemistry, biology, DMPK and peptide discovery.
Through the partnership, eligible companies introduced by SBC will be able to access support through the o2h Kickstarter programme, designed to give early-stage biotech companies additional scientific resource at a critical stage of their development.
Support available can include a dedicated team of synthetic chemists for up to six months, alongside ADME, biology and project management expertise, helping companies accelerate drug discovery programmes, generate critical scientific data and progress towards their next milestones.

Marco Delise PhD, Director of Entrepreneurship and Business Development at Stevenage Bioscience Catalyst, said:

“Supporting early-stage companies is about much more than providing lab space. It’s about connecting founders with the right expertise, resources and partners at the right point in their journey. This collaboration with o2h Discovery complements the support we already provide at SBC by giving companies in our ecosystem access to additional specialist drug discovery capabilities that can help them generate critical data, accelerate their programmes and reach their next scientific and investment milestones.

Partnerships like this are an important part of building a strong, connected ecosystem where promising science has the support it needs to progress.”

The partnership builds on SBC’s wider commitment to creating an environment in which life science companies can start, grow and scale, combining flexible laboratory and office space with access to scientific expertise, investment, networks and a highly connected life sciences community.
Over the past decade, companies based at SBC have attracted more than £4 billion in funding, demonstrating the strength of the ecosystem and its track record in supporting the growth of innovative life sciences businesses.

Sunil Shah, Co-founder of o2h Discovery, said:

“The o2h Kickstarter Award was created to help early-stage biotech companies access the scientific expertise and discovery capabilities needed to reach their next milestone. Over the past few years, we’ve had the privilege of supporting more than 40 startups globally, and the Platinum Partner Programme is a natural extension of that journey. We are delighted to welcome Stevenage Bioscience Catalyst as a Platinum Partner and look forward to working together to help more founders accelerate their science and build successful biotechnology companies.”

The new collaboration will enable SBC and o2h Discovery to identify companies that could benefit from additional drug discovery support, complementing SBC’s existing infrastructure, commercial support and connections to investors and industry.

By expanding the expertise and resources available to companies within its community, SBC continues to strengthen its role in supporting ambitious life sciences businesses as they develop, grow and work towards bringing new therapies to patients.

Find out more about the partnership here

Stevenage Bioscience Catalyst

Message History

Delivery option(s)